Lobbying activity

Q2

LIBERTY PARTNERS GROUP, LLC for ALLIANCE FOR PHYSICAL THERAPY QUALITY AND INNOVATION

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $70,000.00 income

Medicare/Medicaid, Health Issues

View → Q2

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $30,000.00 income

Medicare/Medicaid

View → Q2

LIBERTY PARTNERS GROUP, LLC for ALLIANCE FOR PHYSICAL THERAPY QUALITY AND INNOVATION (OBFA FKA USPA)

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Medicare/Medicaid

View → Q2

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $30,000.00 income

Medicare/Medicaid

View → Q2

PRIME POLICY GROUP for ALLINA HEALTH

2nd Quarter (Apr 1 - June 30) 2025 · Minnesota · House · Senate · $40,000.00 income

Health Issues, Medicare/Medicaid

View → Q2

ONMESSAGE PUBLIC STRATEGIES for AIR METHODS

2nd Quarter (Apr 1 - June 30) 2025 · Colorado · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues

View → Q2

LIBERTY PARTNERS GROUP, LLC for ALLIANCE FOR AMERICA'S PROMISE, INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $150,000.00 income

Veterans, Health Issues, Medicare/Medicaid

View → Q2

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $30,000.00 income

Medicare/Medicaid

View → Q2

WHITMER & WORRALL, LLC for EUROFINS TRANSPLANT GENOMICS INC.

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $30,000.00 income

Medicare/Medicaid

View → Q2

WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy

View → Q2

KING & SPALDING LLP for MCS ADVANTAGE, INC.

2nd Quarter (Apr 1 - June 30) 2025 · PR · House · Senate · $50,000.00 income

Medicare/Medicaid

View → Q2

KING & SPALDING LLP for MOLECULIGHT CORPORATION

2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $70,000.00 income

Medicare/Medicaid

View → Q2

BARNES & THORNBURG, LLP for RIVERVIEW HEALTH

2nd Quarter (Apr 1 - June 30) 2025 · Indiana · House · Senate

Budget/Appropriations, Medicare/Medicaid

View → Q2

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q2

MERCK & CO, INC. for MERCK & CO INC

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Animals

View → Q2

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate

Health Issues, Labor Issues/Antitrust/Workplace, Small Business, Budget/Appropriations

View → Q2

ABBVIE, INC. for ABBVIE INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q2

KING & SPALDING LLP for MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL)

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income

Medicare/Medicaid

View → Q2

CROSSROADS STRATEGIES, LLC for MERCK & CO., INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income

Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign), Budget/Appropriations

View → Q2

KING & SPALDING LLP for MARC COALITION

2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · $80,000.00 income

Medicare/Medicaid

View → Q2

B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $30,000.00 income

Medicare/Medicaid

View → Q2

LMH STRATEGIC SOLUTIONS for ACADIA PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $10,000.00 income

Medicare/Medicaid, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for BIOMARIN PHARMACEUTICAL, INC.

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $10,000.00 income

Medicare/Medicaid, Pharmacy

View → Q2

KING & SPALDING LLP for KANEKA PHARMA AMERICA, LLC

2nd Quarter (Apr 1 - June 30) 2025 · California · House · $30,000.00 income

Medicare/Medicaid

View → 2A

CHECKMATE GOVERNMENT RELATIONS for HEALTH EQUALITY CAMPAIGN

2nd Quarter (Apr 1 - June 30) 2025 · New York · $70,000.00 income

Medicare/Medicaid

View →